What is Sarepta Therapeutics, Inc.'s EBIT?

Sarepta Therapeutics, Inc. (SRPT) reported EBIT of -$300.39M in Q1 2025.

How has Sarepta Therapeutics, Inc.'s EBIT changed year-over-year?

Sarepta Therapeutics, Inc.'s EBIT decreased by 960.6% year-over-year, from $34.91M to -$300.39M.

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

Sarepta Therapeutics, Inc. SRPT EBIT

Discontinued — last reported Q1 '25

EBIT at other companies

PTC TherapeuticsPTCT

$44.96M-95.4%

Capricor TherapeuticsCAPR

-$36.77M-47.2%

PfizerPFE

——

Regeneron PharmaceuticalsREGN

——

BioMarin PharmaceuticalsBMRN

——

InsmedINSM

——

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.76B-63.1%

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Calculated from Sarepta Therapeutics, Inc.’s reported figures.

−$300.4Moperating income−$383.5Mincome before tax−$4.5Minterest expense=-$300.39M

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s EBIT?: Sarepta Therapeutics, Inc. (SRPT) reported EBIT of -$300.39M in Q1 2025.
How has Sarepta Therapeutics, Inc.'s EBIT changed year-over-year?: Sarepta Therapeutics, Inc.'s EBIT decreased by 960.6% year-over-year, from $34.91M to -$300.39M.
What does EBIT mean?: Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.